Fatal Disseminated Tuberculosis and Concurrent Disseminated Cryptococcosis in a Ruxolitinib-treated Patient with Primary Myelofibrosis: A Case Report and Literature Review

Ruxolitinib, a Janus kinase inhibitor, improves symptoms in patients with myelofibrosis. However, its association with the development of opportunistic infections has been a concern. We herein report a 71-year-old man with primary myelofibrosis who developed disseminated tuberculosis and concurrent...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogai, Asuka, Yagi, Kazuma, Ito, Fumimaro, Domoto, Hideharu, Shiomi, Tetsuya, Chin, Kenko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107979/
https://www.ncbi.nlm.nih.gov/pubmed/34565769
http://dx.doi.org/10.2169/internalmedicine.6436-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107979/
https://www.ncbi.nlm.nih.gov/pubmed/34565769
http://dx.doi.org/10.2169/internalmedicine.6436-20

Ejemplares similares